Taysha Gene Therapies Stock Price on September 18, 2024
| TSHA Stock | USD 3.24 0.24 8.00% |
Below is the normalized historical share price chart for Taysha Gene Therapies extending back to September 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Taysha Gene stands at 3.24, as last reported on the 2nd of December, with the highest price reaching 3.30 and the lowest price hitting 3.00 during the day.
If you're considering investing in Taysha Stock, it is important to understand the factors that can impact its price. Taysha Gene appears to be very risky, given 3 months investment horizon. Taysha Gene Therapies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12% return per unit of risk over the last 3 months. By inspecting Taysha Gene's technical indicators, you can evaluate if the expected return of 0.98% is justified by implied risk. Please review Taysha Gene's Risk Adjusted Performance of 0.0994, semi deviation of 4.58, and Coefficient Of Variation of 845.84 to confirm if our risk estimates are consistent with your expectations.
At present, Taysha Gene's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to 2,100, whereas Total Stockholder Equity is forecasted to decline to about 67.6 M. . At present, Taysha Gene's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.03, whereas Price To Sales Ratio is forecasted to decline to 12.64. Taysha Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of September 2020 | 200 Day MA 2.4451 | 50 Day MA 2.0406 | Beta 0.414 |
Taysha |
Sharpe Ratio = 0.1234
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TSHA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.97 actual daily | 70 70% of assets are less volatile |
Expected Return
| 0.98 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Taysha Gene is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Taysha Gene by adding it to a well-diversified portfolio.
Price Book 7.4779 | Enterprise Value Ebitda (0.61) | Price Sales 66.9708 | Shares Float 159.8 M | Wall Street Target Price 6.5909 |
Related Headline
Akero Therapeutics Headline on 18th of September 2024
Disposition of 3871 shares by Catriona Yale of Akero Therape... by Catriona Yale
Filed transaction by Akero Therapeutics Officer: Chief Development Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Taysha Gene Valuation on September 18, 2024
It is possible to determine the worth of Taysha Gene on a given historical date. On September 18, 2024 Taysha was worth 2.17 at the beginning of the trading date compared to the closed value of 2.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Taysha Gene stock. Still, in general, we apply an absolute valuation method to find Taysha Gene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Taysha Gene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Taysha Gene's related companies.
| Open | High | Low | Close | Volume | |
| 2.21 | 2.25 | 2.14 | 2.18 | 1,473,813 | |
09/18/2024 | 2.17 | 2.25 | 2.07 | 2.15 | 1,444,560 |
| 2.24 | 2.29 | 2.14 | 2.19 | 1,946,908 |
| Backtest Taysha Gene | | | Taysha Gene History | | | Taysha Gene Valuation | Previous | Next |
Taysha Gene Trading Date Momentum on September 18, 2024
| On September 19 2024 Taysha Gene Therapies was traded for 2.19 at the closing time. The top price for the day was 2.29 and the lowest listed price was 2.14 . The trading volume for the day was 1.9 M. The trading history from September 19, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 1.86% . The trading price change against the current closing price is 3.72% . |
Taysha Gene Therapies Fundamentals Correlations and Trends
By evaluating Taysha Gene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Taysha Gene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Taysha financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Taysha Gene Stock history
Taysha Gene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Taysha is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Taysha Gene Therapies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Taysha Gene stock prices may prove useful in developing a viable investing in Taysha Gene
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 116.1 M | 121.9 M | |
| Net Loss | -157.1 M | -149.2 M |
Taysha Gene Stock Technical Analysis
Taysha Gene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Taysha Gene Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Taysha Gene Therapies cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Taysha Gene December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Taysha Gene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Taysha Gene shares will generate the highest return on investment. By undertsting and applying Taysha Gene stock market strength indicators, traders can identify Taysha Gene Therapies entry and exit signals to maximize returns
Taysha Gene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Taysha Gene's price direction in advance. Along with the technical and fundamental analysis of Taysha Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Taysha to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0994 | |||
| Jensen Alpha | 0.6414 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.1541 | |||
| Treynor Ratio | 0.4129 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Taysha Stock analysis
When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |